Work

Abstract 5581: The DACH1 gene, frequently co-deleted with BRCA2 in prostate cancer, governs PARP inhibitor resistance

Year: 2024

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2024-5581

Authors: Zhiping Li, Xuanmao Jiao, Taimoor Khan, Danni Li, Shan Zha, Lai Yee Phoon, Li Lan, A. Gordon Robertson, Anthony W. Ashton, Kenneth A. Iczkowski, Alexander D. Borowsky, Alan Ashworth, Richard G. Pestell

Institutions: Baruch S. Blumberg Institute, Columbia University, Duke University, Lankenau Institute for Medical Research, UC Davis Health, University of California, San Francisco

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4393096780

Cites:

Cited by:

Related to: 10